Genpact Accumulated Retained Earnings Deficit vs Total Assets Analysis

G Stock  USD 32.76  0.45  1.39%   
Trend analysis of Genpact Limited balance sheet accounts such as Net Debt of 965.3 M or Retained Earnings of 1.1 B provides information on Genpact's total assets, liabilities, and equity, which is the actual value of Genpact Limited to its prevalent stockholders. By breaking down trends over time using Genpact balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Genpact Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Genpact Limited at a specified time, usually calculated after every quarter, six months, or one year. Genpact Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Genpact and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Genpact currently owns. An asset can also be divided into two categories, current and non-current.

Genpact Balance Sheet Chart

Genpact Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Genpact Limited uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Genpact's Common Stock Shares Outstanding is most likely to increase significantly in the upcoming years. The Genpact's current Common Stock Total Equity is estimated to increase to about 2.6 M, while Total Stockholder Equity is projected to decrease to roughly 1.4 B.

Total Assets

Total assets refers to the total amount of Genpact assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Genpact Limited books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
The current Selling General Administrative is estimated to decrease to about 576 M. The Genpact's current Tax Provision is estimated to increase to about (27.6 M)
 2021 2022 2023 2024 (projected)
Gross Profit1.4B1.5B1.6B902.8M
Total Revenue4.0B4.4B4.5B2.4B

Genpact fundamental ratios Correlations

0.940.860.650.850.440.850.340.930.980.970.950.980.950.670.840.910.520.970.860.870.960.99-0.720.910.01
0.940.70.760.830.190.830.480.960.870.960.790.910.910.770.710.790.520.870.80.670.930.9-0.80.74-0.09
0.860.70.60.550.50.560.010.70.90.750.930.890.830.320.870.80.470.920.790.890.840.9-0.440.91-0.07
0.650.760.60.53-0.090.550.180.630.570.630.520.640.670.530.60.570.420.660.580.360.670.64-0.430.46-0.54
0.850.830.550.530.391.00.520.830.820.90.750.790.770.810.630.860.320.750.640.70.720.79-0.720.750.16
0.440.190.5-0.090.390.38-0.160.20.560.320.620.470.420.090.590.570.00.530.350.620.290.47-0.040.620.23
0.850.830.560.551.00.380.520.830.810.90.750.790.770.810.630.860.330.750.640.70.720.79-0.720.750.14
0.340.480.010.180.52-0.160.520.590.250.50.110.250.170.740.020.180.140.120.10.180.250.21-0.880.180.49
0.930.960.70.630.830.20.830.590.880.980.80.910.860.740.630.790.530.820.820.750.920.89-0.890.780.11
0.980.870.90.570.820.560.810.250.880.930.990.980.930.590.870.930.50.980.860.930.930.98-0.640.970.07
0.970.960.750.630.90.320.90.50.980.930.870.940.90.760.720.880.510.890.840.810.940.94-0.820.850.11
0.950.790.930.520.750.620.750.110.80.990.870.960.90.480.90.920.470.980.840.950.90.97-0.520.980.05
0.980.910.890.640.790.470.790.250.910.980.940.960.950.550.830.90.510.970.910.890.970.99-0.660.92-0.02
0.950.910.830.670.770.420.770.170.860.930.90.90.950.570.780.850.570.950.910.760.930.97-0.590.8-0.15
0.670.770.320.530.810.090.810.740.740.590.760.480.550.570.460.560.380.530.390.40.550.57-0.790.50.17
0.840.710.870.60.630.590.630.020.630.870.720.90.830.780.460.80.290.920.620.80.770.84-0.360.89-0.14
0.910.790.80.570.860.570.860.180.790.930.880.920.90.850.560.80.380.90.840.870.840.9-0.520.910.0
0.520.520.470.420.320.00.330.140.530.50.510.470.510.570.380.290.380.50.620.40.580.57-0.40.41-0.23
0.970.870.920.660.750.530.750.120.820.980.890.980.970.950.530.920.90.50.860.870.940.98-0.530.93-0.11
0.860.80.790.580.640.350.640.10.820.860.840.840.910.910.390.620.840.620.860.760.910.91-0.540.76-0.17
0.870.670.890.360.70.620.70.180.750.930.810.950.890.760.40.80.870.40.870.760.820.88-0.530.980.25
0.960.930.840.670.720.290.720.250.920.930.940.90.970.930.550.770.840.580.940.910.820.97-0.660.85-0.08
0.990.90.90.640.790.470.790.210.890.980.940.970.990.970.570.840.90.570.980.910.880.97-0.630.92-0.05
-0.72-0.8-0.44-0.43-0.72-0.04-0.72-0.88-0.89-0.64-0.82-0.52-0.66-0.59-0.79-0.36-0.52-0.4-0.53-0.54-0.53-0.66-0.63-0.54-0.34
0.910.740.910.460.750.620.750.180.780.970.850.980.920.80.50.890.910.410.930.760.980.850.92-0.540.15
0.01-0.09-0.07-0.540.160.230.140.490.110.070.110.05-0.02-0.150.17-0.140.0-0.23-0.11-0.170.25-0.08-0.05-0.340.15
Click cells to compare fundamentals

Genpact Account Relationship Matchups

Genpact fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets4.5B4.9B5.0B4.6B4.8B3.1B
Total Stockholder Equity1.7B1.8B1.9B1.8B2.2B1.4B
Net Debt1.3B1.3B1.1B1.0B919.3M965.3M
Retained Earnings648.7M741.7M732.5M780.0M1.1B1.1B
Cash467.1M680.4M899.5M646.8M583.7M449.6M
Other Assets478.8M961.1M667.3M439.6M1.00.95
Cash And Short Term Investments467.1M680.4M899.5M646.8M583.7M472.7M
Common Stock Shares Outstanding195.2M195.8M193.0M188.1M185.1M200.1M
Liabilities And Stockholders Equity4.5B4.9B5.0B4.6B4.8B3.1B
Other Stockholder Equity1.6B1.6B1.7B1.8B1.9B1.3B
Total Liab2.8B3.0B3.1B2.8B2.6B1.6B
Total Current Assets1.6B1.7B1.9B1.8B1.9B1.2B
Short Long Term Debt Total1.8B1.9B2.0B1.7B1.5B950.6M
Other Current Liab629.7M694.0M678.2M675.7M674.4M470.9M
Total Current Liabilities910.2M1.2B1.3B1.1B1.3B758.6M
Other Liab192.2M239.9M249.2M208.0M239.2M192.5M
Property Plant And Equipment Net584.9M535.8M485.7M379.1M393.7M285.6M
Current Deferred Revenue97.3M154.7M160.6M160.6M112.4M77.9M
Accounts Payable22.0M13.9M25.0M35.8M27.7M20.2M
Non Current Assets Total2.9B3.1B3.1B2.8B2.9B1.9B
Non Currrent Assets Other217.1M323.8M322.2M450.5M379.6M213.0M
Long Term Debt1.3B1.3B1.3B1.2B824.7M690.1M
Net Receivables914.3M881.0M887.7M994.8M1.1B613.1M
Good Will1.6B1.7B1.7B1.7B1.7B1.2B
Common Stock Total Equity1.9M1.9M1.8M1.8M1.6M2.6M
Non Current Liabilities Total1.9B1.8B1.8B1.7B1.2B966.8M
Inventory121.2M150.1M103.7M1.01.151.09
Other Current Assets49.2M37.3M30.7M138.0M169.0M177.5M
Property Plant And Equipment Gross618.4M585.9M485.7M379.1M984.1M1.0B
Accumulated Other Comprehensive Income(532.0M)(545.3M)(554.4M)(733.1M)(722.6M)(686.4M)
Short Term Debt161.2M340.0M445.0M231.2M503.4M528.6M
Intangible Assets230.9M236.7M169.6M89.7M53.0M50.4M
Common Stock1.9M1.9M1.8M1.8M1.8M2.5M
Property Plant Equipment254.0M231.1M485.7M379.1M436.0M238.5M
Short Term Investments1.8M8.8M5.8M5.4M4.8M4.6M
Net Tangible Assets(116.2M)(98.2M)(3.5M)52.2M47.0M44.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Genpact Limited is a strong investment it is important to analyze Genpact's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genpact's future performance. For an informed investment choice regarding Genpact Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.311
Dividend Share
0.55
Earnings Share
3.41
Revenue Per Share
24.552
Quarterly Revenue Growth
0.04
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.